Northwestern Mutual Wealth Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-10
Closed -$322 3623
2024
Q1
$322 Hold
10
﹤0.01% 3352
2023
Q4
$407 Buy
+10
New +$368 ﹤0.01% 3296
2019
Q4
Sell
-1
Closed 2467
2019
Q3
$0 Buy
+1
New +$164 ﹤0.01% 2550
2017
Q1
Sell
-44
Closed -$3K 2152
2016
Q4
$3K Buy
+44
New +$2.71K ﹤0.01% 1961
2016
Q2
Sell
-200
Closed -$8K 2129
2016
Q1
$8K Buy
+200
New +$9.28K ﹤0.01% 1507

Other funds holding LKFT

Northwestern Mutual Wealth Management's LKFT Position: Q2 2024 in Review

Northwestern Mutual Wealth Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2024, closing a stake of 10 shares — an estimated $322 sold.

Northwestern Mutual Wealth Management first reported a position in LKFT in Q1 2016 and held it in 5 quarters. The position peaked at $8K in Q1 2016. 85 funds tracked by Wall St. Rank hold LKFT as of Q2 2024.

  • Northwestern Mutual Wealth Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2024 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 10 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2024, an estimated $322.
  • Northwestern Mutual Wealth Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2016 and held it in 5 quarters.
  • Northwestern Mutual Wealth Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $8K in Q1 2016.
  • 85 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2024.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2024, filed 16 Aug 2024.